Search research articles
Contact Us
Filters
Showing results (481-490 of 525) with videos related to
Page
of 53
Sort By:
Science Translational Medicine
|
April 15, 2021
Imaging <i>Enterobacterales</i> infections in patients using pathogen-specific positron emission tomography
Alvaro A Ordonez, Luz M Wintaco, Filipa Mota, et al.
Clinical Nuclear Medicine
|
August 15, 2017
18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology
Baris Turkbey, Esther Mena, Liza Lindenberg, et al.
The Journal of Urology
|
July 25, 2017
Prostate Specific Membrane Antigen Targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study
Michael A Gorin, Steven P Rowe, Hiten D Patel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 4, 2012
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer
Steve Y Cho, Kenneth L Gage, Ronnie C Mease, et al.
Neurobiology of Disease
|
December 3, 2014
Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study
Jennifer M Coughlin, Yuchuan Wang, Cynthia A Munro, et al.
Journal of Neuroinflammation
|
December 21, 2018
Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [<sup>11</sup>C]DPA-713 PET
Jennifer M Coughlin, Ting Yang, Alison W Rebman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2021
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A Zukotynski, Urban Emmenegger, Sebastien Hotte, et al.
BMC Cancer
|
July 1, 2017
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
Noura Radwan, Ryan Phillips, Ashley Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2018
Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy
Shanshan Jiang, Charles G Eberhart, Michael Lim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 26, 2024
Efficacy and Toxicity of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
Vishnu Murthy, Andrew F Voter, Kathleen Nguyen, et al.
Page
of 53
Search research articles
Search
Showing results (481-490 of 525) with videos related to
Sort By:
Page
of 53
Science Translational Medicine
|
April 15, 2021
Imaging <i>Enterobacterales</i> infections in patients using pathogen-specific positron emission tomography
Alvaro A Ordonez, Luz M Wintaco, Filipa Mota, et al.
Clinical Nuclear Medicine
|
August 15, 2017
18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology
Baris Turkbey, Esther Mena, Liza Lindenberg, et al.
The Journal of Urology
|
July 25, 2017
Prostate Specific Membrane Antigen Targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study
Michael A Gorin, Steven P Rowe, Hiten D Patel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 4, 2012
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer
Steve Y Cho, Kenneth L Gage, Ronnie C Mease, et al.
Neurobiology of Disease
|
December 3, 2014
Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study
Jennifer M Coughlin, Yuchuan Wang, Cynthia A Munro, et al.
Journal of Neuroinflammation
|
December 21, 2018
Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [<sup>11</sup>C]DPA-713 PET
Jennifer M Coughlin, Ting Yang, Alison W Rebman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2021
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A Zukotynski, Urban Emmenegger, Sebastien Hotte, et al.
BMC Cancer
|
July 1, 2017
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
Noura Radwan, Ryan Phillips, Ashley Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2018
Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy
Shanshan Jiang, Charles G Eberhart, Michael Lim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 26, 2024
Efficacy and Toxicity of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
Vishnu Murthy, Andrew F Voter, Kathleen Nguyen, et al.
Page
of 53